Brief: Fibrobiologics Announces Pricing Of $4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
19/11/2025 13:37
Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS ANNOUNCES PRICING OF $4 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nGNX471MxN Further company coverage: FBLG.O
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts